[HTML][HTML] An introduction to the Marburg virus vaccine consortium, MARVAC
The emergence of Marburg virus (MARV) in Guinea and Ghana triggered the assembly of
the MARV vaccine “MARVAC” consortium representing leaders in the field of vaccine …
the MARV vaccine “MARVAC” consortium representing leaders in the field of vaccine …
[HTML][HTML] Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges
The Marburg virus (MV), identified in 1967, has caused deadly outbreaks worldwide, the
mortality rate of Marburg virus disease (MVD) varies depending on the outbreak and virus …
mortality rate of Marburg virus disease (MVD) varies depending on the outbreak and virus …
[HTML][HTML] Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques
A Marzi, P Fletcher, F Feldmann, G Saturday… - The Lancet …, 2023 - thelancet.com
Summary Background The recent Sudan virus (SUDV) outbreak in Uganda highlights the
need for rapid response capabilities, including development of vaccines against emerging …
need for rapid response capabilities, including development of vaccines against emerging …
[HTML][HTML] A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever
Lassa virus (LASV) is recognized by the World Health Organization as one of the top five
pathogens likely to cause a severe outbreak. A recent unprecedented resurgence of LASV …
pathogens likely to cause a severe outbreak. A recent unprecedented resurgence of LASV …
Marburg virus disease: a deadly rare virus is coming
F Zhao, Y He, H Lu - Bioscience trends, 2022 - jstage.jst.go.jp
Two cases of the deadly Marburgvirus were reported in Ghana, which might be a new global
virus alert following COVID-19 and novel monkeypox. Thus far, there is no vaccine or …
virus alert following COVID-19 and novel monkeypox. Thus far, there is no vaccine or …
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
R Hunegnaw, AN Honko, L Wang, D Carr… - Science translational …, 2022 - science.org
Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality
rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent …
rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent …
[HTML][HTML] A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
Background Marburg virus (MARV), an Ebola-like virus, remains an eminent threat to public
health as demonstrated by its high associated mortality rate (23–90%) and recent …
health as demonstrated by its high associated mortality rate (23–90%) and recent …
[HTML][HTML] Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
Background Marburg virus (MARV) is the causative agent of Marburg virus disease (MVD)
which has a case fatality rate up to∼ 90% in humans. Recently, there were cases reported …
which has a case fatality rate up to∼ 90% in humans. Recently, there were cases reported …
Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?
Understanding the origins of past and present viral epidemics is critical in preparing for
future outbreaks. Many viruses, including SARS-CoV-2, have led to significant …
future outbreaks. Many viruses, including SARS-CoV-2, have led to significant …
A highly attenuated panfilovirus VesiculoVax vaccine rapidly protects nonhuman primates against Marburg virus and 3 species of Ebola virus
C Woolsey, V Borisevich, KN Agans… - The Journal of …, 2023 - academic.oup.com
Abstract Background The family Filoviridae consists of several virus members known to
cause significant mortality and disease in humans. Among these, Ebola virus (EBOV) …
cause significant mortality and disease in humans. Among these, Ebola virus (EBOV) …